AIkido Pharma (AIKI) Competitors $5.50 +0.28 (+5.36%) As of 07/16/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsInsider TradesSEC FilingsTrendsBuy This Stock AIKI vs. LUNA, DKDCA, CLLS, ACTU, GNLX, SKYE, INFU, TNYA, IOBT, and SGMOShould you be buying AIkido Pharma stock or one of its competitors? The main competitors of AIkido Pharma include Luna Innovations (LUNA), Data Knights Acquisition (DKDCA), Cellectis (CLLS), Actuate Therapeutics (ACTU), Genelux (GNLX), Skye Bioscience (SKYE), InfuSystem (INFU), Tenaya Therapeutics (TNYA), IO Biotech (IOBT), and Sangamo Therapeutics (SGMO). AIkido Pharma vs. Its Competitors Luna Innovations Data Knights Acquisition Cellectis Actuate Therapeutics Genelux Skye Bioscience InfuSystem Tenaya Therapeutics IO Biotech Sangamo Therapeutics AIkido Pharma (NASDAQ:AIKI) and Luna Innovations (NASDAQ:LUNA) are both small-cap commercial physical research industry companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, analyst recommendations, valuation, earnings, risk, institutional ownership, profitability and media sentiment. Which has higher earnings and valuation, AIKI or LUNA? Luna Innovations has higher revenue and earnings than AIkido Pharma. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAIkido PharmaN/AN/A-$7.17M-$3.88-1.42Luna Innovations$116.61M0.24$9.28MN/AN/A Do institutionals and insiders hold more shares of AIKI or LUNA? 10.9% of AIkido Pharma shares are owned by institutional investors. Comparatively, 87.5% of Luna Innovations shares are owned by institutional investors. 8.6% of AIkido Pharma shares are owned by insiders. Comparatively, 7.6% of Luna Innovations shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Which has more volatility and risk, AIKI or LUNA? AIkido Pharma has a beta of 0.93, meaning that its stock price is 7% less volatile than the S&P 500. Comparatively, Luna Innovations has a beta of 1.96, meaning that its stock price is 96% more volatile than the S&P 500. Is AIKI or LUNA more profitable? Luna Innovations' return on equity of 0.00% beat AIkido Pharma's return on equity.Company Net Margins Return on Equity Return on Assets AIkido PharmaN/A -18.21% -16.94% Luna Innovations N/A N/A N/A Does the media prefer AIKI or LUNA? In the previous week, Luna Innovations had 7 more articles in the media than AIkido Pharma. MarketBeat recorded 7 mentions for Luna Innovations and 0 mentions for AIkido Pharma. Luna Innovations' average media sentiment score of 0.37 beat AIkido Pharma's score of 0.00 indicating that Luna Innovations is being referred to more favorably in the news media. Company Overall Sentiment AIkido Pharma Neutral Luna Innovations Neutral SummaryLuna Innovations beats AIkido Pharma on 8 of the 9 factors compared between the two stocks. Get AIkido Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for AIKI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding AIKI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AIKI vs. The Competition Export to ExcelMetricAIkido PharmaCommercial physical research IndustryMedical SectorNASDAQ ExchangeMarket Cap$30.17M$19.88M$5.50B$9.38BDividend YieldN/AN/A4.25%4.06%P/E Ratio-1.42N/A28.1019.86Price / SalesN/A0.24380.1579.06Price / CashN/A57.2335.5357.53Price / Book0.290.298.265.72Net Income-$7.17M-$525K$3.24B$257.80M7 Day Performance10.66%2.76%0.50%1.07%1 Month Performance9.56%23.87%7.99%11.31%1 Year Performance195.70%26.31%28.68%17.01% AIkido Pharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AIKIAIkido PharmaN/A$5.50+5.4%N/A+180.6%$30.17MN/A-1.424High Trading VolumeLUNALuna Innovations0.3547 of 5 stars$0.85-1.2%N/A-72.2%$28.87M$116.61M0.00390DKDCAData Knights AcquisitionN/A$0.55-9.6%N/A-47.5%$2.85MN/A-2.902Gap DownHigh Trading VolumeCLLSCellectis3.4306 of 5 stars$2.11-1.9%$4.00+89.6%-8.3%$117.27M$49.22M-2.45290Positive NewsGap UpACTUActuate Therapeutics2.9437 of 5 stars$5.97-3.7%$20.50+243.4%N/A$117.13MN/A0.0010Positive NewsGap UpGNLXGenelux1.2152 of 5 stars$3.08-8.9%$17.75+476.3%+16.8%$116.22MN/A-3.5010News CoverageSKYESkye Bioscience2.1636 of 5 stars$3.74-4.8%$16.60+343.9%-44.4%$115.85MN/A-4.5611INFUInfuSystem3.1425 of 5 stars$5.48-2.3%$13.00+137.2%N/A$115.17M$137.58M91.35410TNYATenaya Therapeutics3.5042 of 5 stars$0.69-3.0%$6.25+805.8%-81.0%$112.24MN/A-0.59110IOBTIO Biotech3.6559 of 5 stars$1.70flat$9.33+449.0%+42.1%$112.00MN/A-1.1430News CoverageSGMOSangamo Therapeutics2.7301 of 5 stars$0.48-4.0%$4.50+837.1%+4.7%$111.97M$57.80M-1.23480Positive News Related Companies and Tools Related Companies Luna Innovations Alternatives Data Knights Acquisition Alternatives Cellectis Alternatives Actuate Therapeutics Alternatives Genelux Alternatives Skye Bioscience Alternatives InfuSystem Alternatives Tenaya Therapeutics Alternatives IO Biotech Alternatives Sangamo Therapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AIKI) was last updated on 7/17/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AIkido Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AIkido Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
